))
From Lab to Market: Ovarian Cancer Diagnostic Innovation with Aspira Women’s Health - Episode 229
Manage episode 403606054 series 2851689
Innhold levert av Dr. Brittany Barreto. Alt podcastinnhold, inkludert episoder, grafikk og podcastbeskrivelser, lastes opp og leveres direkte av Dr. Brittany Barreto eller deres podcastplattformpartner. Hvis du tror at noen bruker det opphavsrettsbeskyttede verket ditt uten din tillatelse, kan du følge prosessen skissert her https://no.player.fm/legal.
Join us as we talk to Nicole Sandford, CEO of Aspira Women’s Health. Aspira Women’s Health is a publicly traded women’s health diagnostics company whose suite of non-invasive ovarian cancer blood tests are helping ensure women receive the best care. Nicole has an extensive background as a highly skilled operator and took the helm at Aspira in early 2022. In their conversation, Nicole and Brittany discuss the challenges unique to ovarian cancer detection and treatment, why Aspira’s products are so revolutionary, and how the company is going after endometriosis next. Remember to like, rate and subscribe and enjoy the episode!
…
continue reading
253 episoder
Del
